President Donald Trump said Thursday his administration has reached a deal to lower the cost of the blockbuster GLP-1 weight loss drugs, Wegovy and Zepbound — a move that could significantly expand access to the wildly popular drugs, though some details remained unclear.

Under the deal, the monthly out-of-pocket cost of the drugs could range from $50 to around $350, depending on the dosage and insurance coverage.

Currently, Eli Lilly's Zepbound and Novo Nordisk's Wegovy carry list prices above $1,000 a month, although both companies have introduced lower cost options for patients paying in cash and purchasing the drugs directly through their websites. To further expand access, Costco recently announced it would sell Wegovy and Ozempic for $499 for people who paid cash, while Walmart la

See Full Page